Studio delle PIM chinasi come possibili bersagli terapeutici nelle artriti infiammatorie

Title

Code

REUMAPIM

Type

Sperimentale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366093

simona.neri@ior.it

Neri Simona, Biologist

Biologist

Medicine and Rheumatology

Operational unit that carry out the study

departmental simple unit

Medicina e reumatologia

Temporary Head

Faldini Cesare, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. REUMAPIM

Tuesday 2 May 2023, 16:45

PG0006736_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Studio delle PIM chinasi come possibili bersagli terapeutici nelle artriti infiammatorie

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in